nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—ALB—multiple sclerosis	0.249	1	CbGaD
Clomipramine—CYP2D6—Fingolimod—multiple sclerosis	0.0449	0.114	CbGbCtD
Clomipramine—ALB—Prednisone—multiple sclerosis	0.0356	0.09	CbGbCtD
Clomipramine—ABCB1—Methylprednisolone—multiple sclerosis	0.0307	0.0777	CbGbCtD
Clomipramine—CYP3A4—Fingolimod—multiple sclerosis	0.0286	0.0722	CbGbCtD
Clomipramine—CYP2C19—Prednisone—multiple sclerosis	0.0231	0.0583	CbGbCtD
Clomipramine—ABCB1—Mitoxantrone—multiple sclerosis	0.0224	0.0567	CbGbCtD
Clomipramine—ABCB1—Betamethasone—multiple sclerosis	0.02	0.0505	CbGbCtD
Clomipramine—ABCB1—Prednisolone—multiple sclerosis	0.0197	0.0498	CbGbCtD
Clomipramine—ABCB1—Prednisone—multiple sclerosis	0.0186	0.0471	CbGbCtD
Clomipramine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0184	0.0465	CbGbCtD
Clomipramine—ALB—Methotrexate—multiple sclerosis	0.0179	0.0451	CbGbCtD
Clomipramine—CYP2C19—Dexamethasone—multiple sclerosis	0.0144	0.0364	CbGbCtD
Clomipramine—HTR2A—trigeminal nucleus—multiple sclerosis	0.0141	0.215	CbGeAlD
Clomipramine—CYP3A4—Triamcinolone—multiple sclerosis	0.0139	0.0353	CbGbCtD
Clomipramine—CYP3A4—Mitoxantrone—multiple sclerosis	0.0134	0.034	CbGbCtD
Clomipramine—CYP3A4—Betamethasone—multiple sclerosis	0.012	0.0303	CbGbCtD
Clomipramine—CYP3A4—Prednisolone—multiple sclerosis	0.0118	0.0299	CbGbCtD
Clomipramine—ABCB1—Dexamethasone—multiple sclerosis	0.0116	0.0294	CbGbCtD
Clomipramine—CYP3A4—Prednisone—multiple sclerosis	0.0112	0.0282	CbGbCtD
Clomipramine—CYP2D6—Dexamethasone—multiple sclerosis	0.0109	0.0277	CbGbCtD
Clomipramine—ABCB1—Methotrexate—multiple sclerosis	0.00934	0.0236	CbGbCtD
Clomipramine—CYP3A4—Dexamethasone—multiple sclerosis	0.00696	0.0176	CbGbCtD
Clomipramine—HTR2A—trigeminal nerve—multiple sclerosis	0.0037	0.0564	CbGeAlD
Clomipramine—HTR2A—pons—multiple sclerosis	0.0026	0.0397	CbGeAlD
Clomipramine—SLC6A2—nerve—multiple sclerosis	0.00225	0.0343	CbGeAlD
Clomipramine—ADRA2A—peripheral nervous system—multiple sclerosis	0.00204	0.0311	CbGeAlD
Clomipramine—HTR2A—pineal body—multiple sclerosis	0.00186	0.0284	CbGeAlD
Clomipramine—HTR2A—peripheral nervous system—multiple sclerosis	0.00173	0.0264	CbGeAlD
Clomipramine—HTR2A—nerve—multiple sclerosis	0.00135	0.0206	CbGeAlD
Clomipramine—GSTP1—retina—multiple sclerosis	0.00127	0.0194	CbGeAlD
Clomipramine—HTR2C—brainstem—multiple sclerosis	0.00116	0.0176	CbGeAlD
Clomipramine—SLC6A4—brainstem—multiple sclerosis	0.0011	0.0167	CbGeAlD
Clomipramine—HTR6—nervous system—multiple sclerosis	0.00105	0.016	CbGeAlD
Clomipramine—HTR6—central nervous system—multiple sclerosis	0.00101	0.0154	CbGeAlD
Clomipramine—SLC6A2—brainstem—multiple sclerosis	0.000965	0.0147	CbGeAlD
Clomipramine—HRH2—nervous system—multiple sclerosis	0.000958	0.0146	CbGeAlD
Clomipramine—HRH2—central nervous system—multiple sclerosis	0.000923	0.0141	CbGeAlD
Clomipramine—GSTP1—medulla oblongata—multiple sclerosis	0.000918	0.014	CbGeAlD
Clomipramine—GSTP1—midbrain—multiple sclerosis	0.000839	0.0128	CbGeAlD
Clomipramine—GSTP1—spinal cord—multiple sclerosis	0.000819	0.0125	CbGeAlD
Clomipramine—HTR2C—medulla oblongata—multiple sclerosis	0.000806	0.0123	CbGeAlD
Clomipramine—HTR6—brain—multiple sclerosis	0.000801	0.0122	CbGeAlD
Clomipramine—HTR2C—midbrain—multiple sclerosis	0.000737	0.0112	CbGeAlD
Clomipramine—HRH2—brain—multiple sclerosis	0.000733	0.0112	CbGeAlD
Clomipramine—HTR2C—spinal cord—multiple sclerosis	0.000719	0.011	CbGeAlD
Clomipramine—SLC6A4—midbrain—multiple sclerosis	0.000698	0.0107	CbGeAlD
Clomipramine—GSTP1—nervous system—multiple sclerosis	0.00069	0.0105	CbGeAlD
Clomipramine—SLC6A4—spinal cord—multiple sclerosis	0.000681	0.0104	CbGeAlD
Clomipramine—SLC6A2—medulla oblongata—multiple sclerosis	0.000673	0.0103	CbGeAlD
Clomipramine—GSTP1—central nervous system—multiple sclerosis	0.000664	0.0101	CbGeAlD
Clomipramine—GSTP1—cerebellum—multiple sclerosis	0.000649	0.0099	CbGeAlD
Clomipramine—HTR2C—nervous system—multiple sclerosis	0.000606	0.00924	CbGeAlD
Clomipramine—HTR2C—central nervous system—multiple sclerosis	0.000583	0.00889	CbGeAlD
Clomipramine—HTR2A—brainstem—multiple sclerosis	0.00058	0.00884	CbGeAlD
Clomipramine—SLC6A4—nervous system—multiple sclerosis	0.000574	0.00876	CbGeAlD
Clomipramine—HTR2B—nervous system—multiple sclerosis	0.000569	0.00868	CbGeAlD
Clomipramine—HTR2A—retina—multiple sclerosis	0.00056	0.00853	CbGeAlD
Clomipramine—SLC6A4—central nervous system—multiple sclerosis	0.000553	0.00843	CbGeAlD
Clomipramine—HTR2B—central nervous system—multiple sclerosis	0.000548	0.00835	CbGeAlD
Clomipramine—CYP2D6—brainstem—multiple sclerosis	0.000528	0.00806	CbGeAlD
Clomipramine—GSTP1—brain—multiple sclerosis	0.000527	0.00804	CbGeAlD
Clomipramine—SLC6A2—nervous system—multiple sclerosis	0.000506	0.00771	CbGeAlD
Clomipramine—SLC6A2—central nervous system—multiple sclerosis	0.000487	0.00742	CbGeAlD
Clomipramine—ADRA2A—medulla oblongata—multiple sclerosis	0.000476	0.00725	CbGeAlD
Clomipramine—HTR2C—brain—multiple sclerosis	0.000463	0.00706	CbGeAlD
Clomipramine—ALB—brain—multiple sclerosis	0.000452	0.00689	CbGeAlD
Clomipramine—SLC6A4—brain—multiple sclerosis	0.000439	0.00669	CbGeAlD
Clomipramine—HTR2B—brain—multiple sclerosis	0.000435	0.00663	CbGeAlD
Clomipramine—ADRA2A—midbrain—multiple sclerosis	0.000435	0.00663	CbGeAlD
Clomipramine—ADRA2A—spinal cord—multiple sclerosis	0.000424	0.00647	CbGeAlD
Clomipramine—HTR2A—medulla oblongata—multiple sclerosis	0.000404	0.00617	CbGeAlD
Clomipramine—SLC6A2—brain—multiple sclerosis	0.000386	0.00589	CbGeAlD
Clomipramine—HTR2A—midbrain—multiple sclerosis	0.00037	0.00564	CbGeAlD
Clomipramine—ABCB1—retina—multiple sclerosis	0.000367	0.00559	CbGeAlD
Clomipramine—HTR2A—spinal cord—multiple sclerosis	0.000361	0.0055	CbGeAlD
Clomipramine—ADRA2A—nervous system—multiple sclerosis	0.000357	0.00545	CbGeAlD
Clomipramine—ADRA2A—central nervous system—multiple sclerosis	0.000344	0.00525	CbGeAlD
Clomipramine—ADRA2A—cerebellum—multiple sclerosis	0.000336	0.00513	CbGeAlD
Clomipramine—HTR2A—nervous system—multiple sclerosis	0.000304	0.00463	CbGeAlD
Clomipramine—HTR2A—central nervous system—multiple sclerosis	0.000293	0.00446	CbGeAlD
Clomipramine—HTR2A—cerebellum—multiple sclerosis	0.000286	0.00436	CbGeAlD
Clomipramine—CYP3A4—nervous system—multiple sclerosis	0.000281	0.00429	CbGeAlD
Clomipramine—CYP2D6—nervous system—multiple sclerosis	0.000277	0.00422	CbGeAlD
Clomipramine—ADRA2A—brain—multiple sclerosis	0.000273	0.00417	CbGeAlD
Clomipramine—CYP3A4—central nervous system—multiple sclerosis	0.000271	0.00413	CbGeAlD
Clomipramine—CYP2D6—central nervous system—multiple sclerosis	0.000267	0.00406	CbGeAlD
Clomipramine—ABCB1—medulla oblongata—multiple sclerosis	0.000265	0.00404	CbGeAlD
Clomipramine—CYP2D6—cerebellum—multiple sclerosis	0.00026	0.00397	CbGeAlD
Clomipramine—ABCB1—midbrain—multiple sclerosis	0.000242	0.00369	CbGeAlD
Clomipramine—ABCB1—spinal cord—multiple sclerosis	0.000236	0.0036	CbGeAlD
Clomipramine—HTR2A—brain—multiple sclerosis	0.000232	0.00354	CbGeAlD
Clomipramine—Triflupromazine—BCHE—multiple sclerosis	0.000212	0.287	CrCbGaD
Clomipramine—CYP2D6—brain—multiple sclerosis	0.000212	0.00323	CbGeAlD
Clomipramine—ABCB1—nervous system—multiple sclerosis	0.000199	0.00304	CbGeAlD
Clomipramine—ABCB1—central nervous system—multiple sclerosis	0.000192	0.00292	CbGeAlD
Clomipramine—ABCB1—cerebellum—multiple sclerosis	0.000187	0.00286	CbGeAlD
Clomipramine—ABCB1—brain—multiple sclerosis	0.000152	0.00232	CbGeAlD
Clomipramine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000108	0.000479	CcSEcCtD
Clomipramine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000108	0.000479	CcSEcCtD
Clomipramine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000108	0.000479	CcSEcCtD
Clomipramine—Epistaxis—Methotrexate—multiple sclerosis	0.000108	0.000479	CcSEcCtD
Clomipramine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000108	0.000478	CcSEcCtD
Clomipramine—Paraesthesia—Prednisolone—multiple sclerosis	0.000108	0.000478	CcSEcCtD
Clomipramine—Tachycardia—Triamcinolone—multiple sclerosis	0.000108	0.000478	CcSEcCtD
Clomipramine—Mental disorder—Prednisone—multiple sclerosis	0.000108	0.000477	CcSEcCtD
Clomipramine—Nausea—Azathioprine—multiple sclerosis	0.000108	0.000477	CcSEcCtD
Clomipramine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000108	0.000477	CcSEcCtD
Clomipramine—Skin disorder—Methylprednisolone—multiple sclerosis	0.000107	0.000475	CcSEcCtD
Clomipramine—Malnutrition—Prednisone—multiple sclerosis	0.000107	0.000474	CcSEcCtD
Clomipramine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000107	0.000474	CcSEcCtD
Clomipramine—Agranulocytosis—Methotrexate—multiple sclerosis	0.000107	0.000473	CcSEcCtD
Clomipramine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000107	0.000473	CcSEcCtD
Clomipramine—Convulsion—Betamethasone—multiple sclerosis	0.000107	0.000472	CcSEcCtD
Clomipramine—Convulsion—Dexamethasone—multiple sclerosis	0.000107	0.000472	CcSEcCtD
Clomipramine—Hypertension—Betamethasone—multiple sclerosis	0.000106	0.00047	CcSEcCtD
Clomipramine—Hypertension—Dexamethasone—multiple sclerosis	0.000106	0.00047	CcSEcCtD
Clomipramine—Asthenia—Mitoxantrone—multiple sclerosis	0.000105	0.000466	CcSEcCtD
Clomipramine—Myalgia—Betamethasone—multiple sclerosis	0.000105	0.000464	CcSEcCtD
Clomipramine—Myalgia—Dexamethasone—multiple sclerosis	0.000105	0.000464	CcSEcCtD
Clomipramine—Anxiety—Betamethasone—multiple sclerosis	0.000104	0.000462	CcSEcCtD
Clomipramine—Anxiety—Dexamethasone—multiple sclerosis	0.000104	0.000462	CcSEcCtD
Clomipramine—Discomfort—Betamethasone—multiple sclerosis	0.000104	0.000458	CcSEcCtD
Clomipramine—Discomfort—Dexamethasone—multiple sclerosis	0.000104	0.000458	CcSEcCtD
Clomipramine—Hypotension—Methylprednisolone—multiple sclerosis	0.000103	0.000457	CcSEcCtD
Clomipramine—Pain—Prednisolone—multiple sclerosis	0.000103	0.000456	CcSEcCtD
Clomipramine—Hepatitis—Methotrexate—multiple sclerosis	0.000103	0.000455	CcSEcCtD
Clomipramine—Pharyngitis—Methotrexate—multiple sclerosis	0.000102	0.000452	CcSEcCtD
Clomipramine—Chlorpromazine—BCHE—multiple sclerosis	0.000102	0.138	CrCbGaD
Clomipramine—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000102	0.00045	CcSEcCtD
Clomipramine—Vision blurred—Prednisone—multiple sclerosis	0.000101	0.000447	CcSEcCtD
Clomipramine—Urethral disorder—Methotrexate—multiple sclerosis	0.000101	0.000446	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000101	0.000446	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000101	0.000445	CcSEcCtD
Clomipramine—Oedema—Betamethasone—multiple sclerosis	0.0001	0.000445	CcSEcCtD
Clomipramine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.0001	0.000445	CcSEcCtD
Clomipramine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.0001	0.000445	CcSEcCtD
Clomipramine—Oedema—Dexamethasone—multiple sclerosis	0.0001	0.000445	CcSEcCtD
Clomipramine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.0001	0.000444	CcSEcCtD
Clomipramine—Insomnia—Triamcinolone—multiple sclerosis	0.0001	0.000443	CcSEcCtD
Clomipramine—Insomnia—Methylprednisolone—multiple sclerosis	9.99e-05	0.000442	CcSEcCtD
Clomipramine—Ill-defined disorder—Prednisone—multiple sclerosis	9.95e-05	0.00044	CcSEcCtD
Clomipramine—Paraesthesia—Triamcinolone—multiple sclerosis	9.94e-05	0.00044	CcSEcCtD
Clomipramine—Feeling abnormal—Prednisolone—multiple sclerosis	9.92e-05	0.000439	CcSEcCtD
Clomipramine—Paraesthesia—Methylprednisolone—multiple sclerosis	9.92e-05	0.000439	CcSEcCtD
Clomipramine—Visual impairment—Methotrexate—multiple sclerosis	9.92e-05	0.000439	CcSEcCtD
Clomipramine—Anaemia—Prednisone—multiple sclerosis	9.91e-05	0.000438	CcSEcCtD
Clomipramine—Shock—Betamethasone—multiple sclerosis	9.89e-05	0.000437	CcSEcCtD
Clomipramine—Shock—Dexamethasone—multiple sclerosis	9.89e-05	0.000437	CcSEcCtD
Clomipramine—Dyspnoea—Triamcinolone—multiple sclerosis	9.87e-05	0.000437	CcSEcCtD
Clomipramine—Nervous system disorder—Betamethasone—multiple sclerosis	9.85e-05	0.000436	CcSEcCtD
Clomipramine—Nervous system disorder—Dexamethasone—multiple sclerosis	9.85e-05	0.000436	CcSEcCtD
Clomipramine—Agitation—Prednisone—multiple sclerosis	9.85e-05	0.000436	CcSEcCtD
Clomipramine—Thrombocytopenia—Betamethasone—multiple sclerosis	9.84e-05	0.000435	CcSEcCtD
Clomipramine—Thrombocytopenia—Dexamethasone—multiple sclerosis	9.84e-05	0.000435	CcSEcCtD
Clomipramine—Tachycardia—Dexamethasone—multiple sclerosis	9.81e-05	0.000434	CcSEcCtD
Clomipramine—Tachycardia—Betamethasone—multiple sclerosis	9.81e-05	0.000434	CcSEcCtD
Clomipramine—Dyspepsia—Triamcinolone—multiple sclerosis	9.75e-05	0.000431	CcSEcCtD
Clomipramine—Dyspepsia—Methylprednisolone—multiple sclerosis	9.73e-05	0.00043	CcSEcCtD
Clomipramine—Hyperhidrosis—Dexamethasone—multiple sclerosis	9.71e-05	0.00043	CcSEcCtD
Clomipramine—Hyperhidrosis—Betamethasone—multiple sclerosis	9.71e-05	0.00043	CcSEcCtD
Clomipramine—Malaise—Prednisone—multiple sclerosis	9.67e-05	0.000428	CcSEcCtD
Clomipramine—Vertigo—Prednisone—multiple sclerosis	9.63e-05	0.000426	CcSEcCtD
Clomipramine—Eye disorder—Methotrexate—multiple sclerosis	9.62e-05	0.000426	CcSEcCtD
Clomipramine—Syncope—Prednisone—multiple sclerosis	9.61e-05	0.000425	CcSEcCtD
Clomipramine—Tinnitus—Methotrexate—multiple sclerosis	9.6e-05	0.000425	CcSEcCtD
Clomipramine—Anorexia—Betamethasone—multiple sclerosis	9.58e-05	0.000424	CcSEcCtD
Clomipramine—Anorexia—Dexamethasone—multiple sclerosis	9.58e-05	0.000424	CcSEcCtD
Clomipramine—Urticaria—Prednisolone—multiple sclerosis	9.57e-05	0.000423	CcSEcCtD
Clomipramine—Cardiac disorder—Methotrexate—multiple sclerosis	9.55e-05	0.000423	CcSEcCtD
Clomipramine—Fatigue—Triamcinolone—multiple sclerosis	9.55e-05	0.000422	CcSEcCtD
Clomipramine—Fatigue—Methylprednisolone—multiple sclerosis	9.53e-05	0.000421	CcSEcCtD
Clomipramine—Pain—Triamcinolone—multiple sclerosis	9.47e-05	0.000419	CcSEcCtD
Clomipramine—Loss of consciousness—Prednisone—multiple sclerosis	9.42e-05	0.000417	CcSEcCtD
Clomipramine—Hypotension—Betamethasone—multiple sclerosis	9.39e-05	0.000415	CcSEcCtD
Clomipramine—Hypotension—Dexamethasone—multiple sclerosis	9.39e-05	0.000415	CcSEcCtD
Clomipramine—Angiopathy—Methotrexate—multiple sclerosis	9.34e-05	0.000413	CcSEcCtD
Clomipramine—Vomiting—Mitoxantrone—multiple sclerosis	9.33e-05	0.000413	CcSEcCtD
Clomipramine—Immune system disorder—Methotrexate—multiple sclerosis	9.3e-05	0.000411	CcSEcCtD
Clomipramine—Convulsion—Prednisone—multiple sclerosis	9.29e-05	0.000411	CcSEcCtD
Clomipramine—Mediastinal disorder—Methotrexate—multiple sclerosis	9.28e-05	0.00041	CcSEcCtD
Clomipramine—Hypertension—Prednisone—multiple sclerosis	9.26e-05	0.00041	CcSEcCtD
Clomipramine—Rash—Mitoxantrone—multiple sclerosis	9.25e-05	0.000409	CcSEcCtD
Clomipramine—Dermatitis—Mitoxantrone—multiple sclerosis	9.25e-05	0.000409	CcSEcCtD
Clomipramine—Chills—Methotrexate—multiple sclerosis	9.24e-05	0.000409	CcSEcCtD
Clomipramine—Headache—Mitoxantrone—multiple sclerosis	9.2e-05	0.000407	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	9.15e-05	0.000405	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	9.15e-05	0.000405	CcSEcCtD
Clomipramine—Arthralgia—Prednisone—multiple sclerosis	9.13e-05	0.000404	CcSEcCtD
Clomipramine—Myalgia—Prednisone—multiple sclerosis	9.13e-05	0.000404	CcSEcCtD
Clomipramine—Feeling abnormal—Triamcinolone—multiple sclerosis	9.13e-05	0.000404	CcSEcCtD
Clomipramine—Feeling abnormal—Methylprednisolone—multiple sclerosis	9.11e-05	0.000403	CcSEcCtD
Clomipramine—Anxiety—Prednisone—multiple sclerosis	9.1e-05	0.000402	CcSEcCtD
Clomipramine—Alopecia—Methotrexate—multiple sclerosis	9.1e-05	0.000402	CcSEcCtD
Clomipramine—Insomnia—Betamethasone—multiple sclerosis	9.09e-05	0.000402	CcSEcCtD
Clomipramine—Insomnia—Dexamethasone—multiple sclerosis	9.09e-05	0.000402	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	9.07e-05	0.000401	CcSEcCtD
Clomipramine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	9.04e-05	0.0004	CcSEcCtD
Clomipramine—Paraesthesia—Dexamethasone—multiple sclerosis	9.02e-05	0.000399	CcSEcCtD
Clomipramine—Paraesthesia—Betamethasone—multiple sclerosis	9.02e-05	0.000399	CcSEcCtD
Clomipramine—Discomfort—Prednisone—multiple sclerosis	9.02e-05	0.000399	CcSEcCtD
Clomipramine—Mental disorder—Methotrexate—multiple sclerosis	9.02e-05	0.000399	CcSEcCtD
Clomipramine—Malnutrition—Methotrexate—multiple sclerosis	8.96e-05	0.000396	CcSEcCtD
Clomipramine—Hypersensitivity—Prednisolone—multiple sclerosis	8.87e-05	0.000393	CcSEcCtD
Clomipramine—Dyspepsia—Dexamethasone—multiple sclerosis	8.84e-05	0.000391	CcSEcCtD
Clomipramine—Dyspepsia—Betamethasone—multiple sclerosis	8.84e-05	0.000391	CcSEcCtD
Clomipramine—Urticaria—Triamcinolone—multiple sclerosis	8.8e-05	0.000389	CcSEcCtD
Clomipramine—Urticaria—Methylprednisolone—multiple sclerosis	8.78e-05	0.000388	CcSEcCtD
Clomipramine—Dysgeusia—Methotrexate—multiple sclerosis	8.77e-05	0.000388	CcSEcCtD
Clomipramine—Body temperature increased—Triamcinolone—multiple sclerosis	8.75e-05	0.000387	CcSEcCtD
Clomipramine—Anaphylactic shock—Prednisone—multiple sclerosis	8.75e-05	0.000387	CcSEcCtD
Clomipramine—Oedema—Prednisone—multiple sclerosis	8.75e-05	0.000387	CcSEcCtD
Clomipramine—Abdominal pain—Methylprednisolone—multiple sclerosis	8.73e-05	0.000386	CcSEcCtD
Clomipramine—Decreased appetite—Betamethasone—multiple sclerosis	8.73e-05	0.000386	CcSEcCtD
Clomipramine—Decreased appetite—Dexamethasone—multiple sclerosis	8.73e-05	0.000386	CcSEcCtD
Clomipramine—Nausea—Mitoxantrone—multiple sclerosis	8.72e-05	0.000386	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	8.67e-05	0.000384	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	8.67e-05	0.000384	CcSEcCtD
Clomipramine—Back pain—Methotrexate—multiple sclerosis	8.67e-05	0.000383	CcSEcCtD
Clomipramine—Fatigue—Betamethasone—multiple sclerosis	8.66e-05	0.000383	CcSEcCtD
Clomipramine—Fatigue—Dexamethasone—multiple sclerosis	8.66e-05	0.000383	CcSEcCtD
Clomipramine—Shock—Prednisone—multiple sclerosis	8.61e-05	0.000381	CcSEcCtD
Clomipramine—Pain—Dexamethasone—multiple sclerosis	8.59e-05	0.00038	CcSEcCtD
Clomipramine—Pain—Betamethasone—multiple sclerosis	8.59e-05	0.00038	CcSEcCtD
Clomipramine—Nervous system disorder—Prednisone—multiple sclerosis	8.58e-05	0.00038	CcSEcCtD
Clomipramine—Tachycardia—Prednisone—multiple sclerosis	8.54e-05	0.000378	CcSEcCtD
Clomipramine—Skin disorder—Prednisone—multiple sclerosis	8.5e-05	0.000376	CcSEcCtD
Clomipramine—Hyperhidrosis—Prednisone—multiple sclerosis	8.46e-05	0.000374	CcSEcCtD
Clomipramine—Vision blurred—Methotrexate—multiple sclerosis	8.44e-05	0.000374	CcSEcCtD
Clomipramine—Anorexia—Prednisone—multiple sclerosis	8.34e-05	0.000369	CcSEcCtD
Clomipramine—Ill-defined disorder—Methotrexate—multiple sclerosis	8.31e-05	0.000368	CcSEcCtD
Clomipramine—Anaemia—Methotrexate—multiple sclerosis	8.28e-05	0.000366	CcSEcCtD
Clomipramine—Feeling abnormal—Dexamethasone—multiple sclerosis	8.28e-05	0.000366	CcSEcCtD
Clomipramine—Feeling abnormal—Betamethasone—multiple sclerosis	8.28e-05	0.000366	CcSEcCtD
Clomipramine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	8.22e-05	0.000364	CcSEcCtD
Clomipramine—Gastrointestinal pain—Betamethasone—multiple sclerosis	8.22e-05	0.000364	CcSEcCtD
Clomipramine—Hypersensitivity—Triamcinolone—multiple sclerosis	8.16e-05	0.000361	CcSEcCtD
Clomipramine—Hypersensitivity—Methylprednisolone—multiple sclerosis	8.14e-05	0.00036	CcSEcCtD
Clomipramine—Malaise—Methotrexate—multiple sclerosis	8.08e-05	0.000358	CcSEcCtD
Clomipramine—Vertigo—Methotrexate—multiple sclerosis	8.05e-05	0.000356	CcSEcCtD
Clomipramine—Acepromazine—ALB—multiple sclerosis	8.04e-05	0.109	CrCbGaD
Clomipramine—Leukopenia—Methotrexate—multiple sclerosis	8.02e-05	0.000355	CcSEcCtD
Clomipramine—Urticaria—Dexamethasone—multiple sclerosis	7.98e-05	0.000353	CcSEcCtD
Clomipramine—Urticaria—Betamethasone—multiple sclerosis	7.98e-05	0.000353	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	7.97e-05	0.000353	CcSEcCtD
Clomipramine—Dizziness—Prednisolone—multiple sclerosis	7.96e-05	0.000352	CcSEcCtD
Clomipramine—Asthenia—Triamcinolone—multiple sclerosis	7.95e-05	0.000352	CcSEcCtD
Clomipramine—Body temperature increased—Dexamethasone—multiple sclerosis	7.94e-05	0.000351	CcSEcCtD
Clomipramine—Abdominal pain—Betamethasone—multiple sclerosis	7.94e-05	0.000351	CcSEcCtD
Clomipramine—Body temperature increased—Betamethasone—multiple sclerosis	7.94e-05	0.000351	CcSEcCtD
Clomipramine—Abdominal pain—Dexamethasone—multiple sclerosis	7.94e-05	0.000351	CcSEcCtD
Clomipramine—Asthenia—Methylprednisolone—multiple sclerosis	7.93e-05	0.000351	CcSEcCtD
Clomipramine—Insomnia—Prednisone—multiple sclerosis	7.91e-05	0.00035	CcSEcCtD
Clomipramine—Thioproperazine—ALB—multiple sclerosis	7.86e-05	0.106	CrCbGaD
Clomipramine—Paraesthesia—Prednisone—multiple sclerosis	7.86e-05	0.000348	CcSEcCtD
Clomipramine—Pruritus—Triamcinolone—multiple sclerosis	7.83e-05	0.000347	CcSEcCtD
Clomipramine—Cough—Methotrexate—multiple sclerosis	7.82e-05	0.000346	CcSEcCtD
Clomipramine—Pruritus—Methylprednisolone—multiple sclerosis	7.82e-05	0.000346	CcSEcCtD
Clomipramine—Convulsion—Methotrexate—multiple sclerosis	7.76e-05	0.000344	CcSEcCtD
Clomipramine—Pipotiazine—ALB—multiple sclerosis	7.73e-05	0.105	CrCbGaD
Clomipramine—Dyspepsia—Prednisone—multiple sclerosis	7.7e-05	0.000341	CcSEcCtD
Clomipramine—Chest pain—Methotrexate—multiple sclerosis	7.63e-05	0.000338	CcSEcCtD
Clomipramine—Arthralgia—Methotrexate—multiple sclerosis	7.63e-05	0.000338	CcSEcCtD
Clomipramine—Myalgia—Methotrexate—multiple sclerosis	7.63e-05	0.000338	CcSEcCtD
Clomipramine—Decreased appetite—Prednisone—multiple sclerosis	7.61e-05	0.000337	CcSEcCtD
Clomipramine—Rash—Prednisolone—multiple sclerosis	7.59e-05	0.000336	CcSEcCtD
Clomipramine—Dermatitis—Prednisolone—multiple sclerosis	7.59e-05	0.000336	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	7.58e-05	0.000335	CcSEcCtD
Clomipramine—Diarrhoea—Methylprednisolone—multiple sclerosis	7.56e-05	0.000334	CcSEcCtD
Clomipramine—Fatigue—Prednisone—multiple sclerosis	7.54e-05	0.000334	CcSEcCtD
Clomipramine—Headache—Prednisolone—multiple sclerosis	7.54e-05	0.000334	CcSEcCtD
Clomipramine—Discomfort—Methotrexate—multiple sclerosis	7.54e-05	0.000333	CcSEcCtD
Clomipramine—Constipation—Prednisone—multiple sclerosis	7.48e-05	0.000331	CcSEcCtD
Clomipramine—Confusional state—Methotrexate—multiple sclerosis	7.37e-05	0.000326	CcSEcCtD
Clomipramine—Dizziness—Triamcinolone—multiple sclerosis	7.32e-05	0.000324	CcSEcCtD
Clomipramine—Anaphylactic shock—Methotrexate—multiple sclerosis	7.31e-05	0.000324	CcSEcCtD
Clomipramine—Dizziness—Methylprednisolone—multiple sclerosis	7.31e-05	0.000323	CcSEcCtD
Clomipramine—Feeling abnormal—Prednisone—multiple sclerosis	7.21e-05	0.000319	CcSEcCtD
Clomipramine—Asthenia—Dexamethasone—multiple sclerosis	7.21e-05	0.000319	CcSEcCtD
Clomipramine—Asthenia—Betamethasone—multiple sclerosis	7.21e-05	0.000319	CcSEcCtD
Clomipramine—Nervous system disorder—Methotrexate—multiple sclerosis	7.17e-05	0.000317	CcSEcCtD
Clomipramine—Thrombocytopenia—Methotrexate—multiple sclerosis	7.16e-05	0.000317	CcSEcCtD
Clomipramine—Gastrointestinal pain—Prednisone—multiple sclerosis	7.16e-05	0.000317	CcSEcCtD
Clomipramine—Nausea—Prednisolone—multiple sclerosis	7.15e-05	0.000316	CcSEcCtD
Clomipramine—Pruritus—Dexamethasone—multiple sclerosis	7.11e-05	0.000315	CcSEcCtD
Clomipramine—Pruritus—Betamethasone—multiple sclerosis	7.11e-05	0.000315	CcSEcCtD
Clomipramine—Skin disorder—Methotrexate—multiple sclerosis	7.1e-05	0.000314	CcSEcCtD
Clomipramine—Hyperhidrosis—Methotrexate—multiple sclerosis	7.07e-05	0.000313	CcSEcCtD
Clomipramine—Vomiting—Triamcinolone—multiple sclerosis	7.04e-05	0.000312	CcSEcCtD
Clomipramine—Vomiting—Methylprednisolone—multiple sclerosis	7.03e-05	0.000311	CcSEcCtD
Clomipramine—Rash—Triamcinolone—multiple sclerosis	6.98e-05	0.000309	CcSEcCtD
Clomipramine—Dermatitis—Triamcinolone—multiple sclerosis	6.98e-05	0.000309	CcSEcCtD
Clomipramine—Anorexia—Methotrexate—multiple sclerosis	6.97e-05	0.000308	CcSEcCtD
Clomipramine—Rash—Methylprednisolone—multiple sclerosis	6.97e-05	0.000308	CcSEcCtD
Clomipramine—Dermatitis—Methylprednisolone—multiple sclerosis	6.96e-05	0.000308	CcSEcCtD
Clomipramine—Urticaria—Prednisone—multiple sclerosis	6.95e-05	0.000308	CcSEcCtD
Clomipramine—Headache—Triamcinolone—multiple sclerosis	6.94e-05	0.000307	CcSEcCtD
Clomipramine—Headache—Methylprednisolone—multiple sclerosis	6.92e-05	0.000306	CcSEcCtD
Clomipramine—Abdominal pain—Prednisone—multiple sclerosis	6.92e-05	0.000306	CcSEcCtD
Clomipramine—Body temperature increased—Prednisone—multiple sclerosis	6.92e-05	0.000306	CcSEcCtD
Clomipramine—Diarrhoea—Betamethasone—multiple sclerosis	6.87e-05	0.000304	CcSEcCtD
Clomipramine—Diarrhoea—Dexamethasone—multiple sclerosis	6.87e-05	0.000304	CcSEcCtD
Clomipramine—Hypotension—Methotrexate—multiple sclerosis	6.83e-05	0.000302	CcSEcCtD
Clomipramine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	6.66e-05	0.000295	CcSEcCtD
Clomipramine—Dizziness—Dexamethasone—multiple sclerosis	6.64e-05	0.000294	CcSEcCtD
Clomipramine—Dizziness—Betamethasone—multiple sclerosis	6.64e-05	0.000294	CcSEcCtD
Clomipramine—Insomnia—Methotrexate—multiple sclerosis	6.61e-05	0.000293	CcSEcCtD
Clomipramine—Nausea—Triamcinolone—multiple sclerosis	6.58e-05	0.000291	CcSEcCtD
Clomipramine—Paraesthesia—Methotrexate—multiple sclerosis	6.57e-05	0.000291	CcSEcCtD
Clomipramine—Nausea—Methylprednisolone—multiple sclerosis	6.56e-05	0.00029	CcSEcCtD
Clomipramine—Dyspnoea—Methotrexate—multiple sclerosis	6.52e-05	0.000288	CcSEcCtD
Clomipramine—Somnolence—Methotrexate—multiple sclerosis	6.5e-05	0.000288	CcSEcCtD
Clomipramine—Hypersensitivity—Prednisone—multiple sclerosis	6.45e-05	0.000285	CcSEcCtD
Clomipramine—Dyspepsia—Methotrexate—multiple sclerosis	6.44e-05	0.000285	CcSEcCtD
Clomipramine—Vomiting—Dexamethasone—multiple sclerosis	6.39e-05	0.000283	CcSEcCtD
Clomipramine—Vomiting—Betamethasone—multiple sclerosis	6.39e-05	0.000283	CcSEcCtD
Clomipramine—Decreased appetite—Methotrexate—multiple sclerosis	6.36e-05	0.000281	CcSEcCtD
Clomipramine—Rash—Dexamethasone—multiple sclerosis	6.34e-05	0.00028	CcSEcCtD
Clomipramine—Rash—Betamethasone—multiple sclerosis	6.34e-05	0.00028	CcSEcCtD
Clomipramine—Dermatitis—Dexamethasone—multiple sclerosis	6.33e-05	0.00028	CcSEcCtD
Clomipramine—Dermatitis—Betamethasone—multiple sclerosis	6.33e-05	0.00028	CcSEcCtD
Clomipramine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	6.31e-05	0.000279	CcSEcCtD
Clomipramine—Fatigue—Methotrexate—multiple sclerosis	6.3e-05	0.000279	CcSEcCtD
Clomipramine—Headache—Betamethasone—multiple sclerosis	6.29e-05	0.000279	CcSEcCtD
Clomipramine—Headache—Dexamethasone—multiple sclerosis	6.29e-05	0.000279	CcSEcCtD
Clomipramine—Asthenia—Prednisone—multiple sclerosis	6.28e-05	0.000278	CcSEcCtD
Clomipramine—Pain—Methotrexate—multiple sclerosis	6.25e-05	0.000277	CcSEcCtD
Clomipramine—Pruritus—Prednisone—multiple sclerosis	6.19e-05	0.000274	CcSEcCtD
Clomipramine—Feeling abnormal—Methotrexate—multiple sclerosis	6.03e-05	0.000267	CcSEcCtD
Clomipramine—Diarrhoea—Prednisone—multiple sclerosis	5.99e-05	0.000265	CcSEcCtD
Clomipramine—Gastrointestinal pain—Methotrexate—multiple sclerosis	5.98e-05	0.000265	CcSEcCtD
Clomipramine—Nortriptyline—ALB—multiple sclerosis	5.97e-05	0.0809	CrCbGaD
Clomipramine—Nausea—Dexamethasone—multiple sclerosis	5.97e-05	0.000264	CcSEcCtD
Clomipramine—Nausea—Betamethasone—multiple sclerosis	5.97e-05	0.000264	CcSEcCtD
Clomipramine—Urticaria—Methotrexate—multiple sclerosis	5.81e-05	0.000257	CcSEcCtD
Clomipramine—Dizziness—Prednisone—multiple sclerosis	5.79e-05	0.000256	CcSEcCtD
Clomipramine—Abdominal pain—Methotrexate—multiple sclerosis	5.78e-05	0.000256	CcSEcCtD
Clomipramine—Body temperature increased—Methotrexate—multiple sclerosis	5.78e-05	0.000256	CcSEcCtD
Clomipramine—Vomiting—Prednisone—multiple sclerosis	5.56e-05	0.000246	CcSEcCtD
Clomipramine—Rash—Prednisone—multiple sclerosis	5.52e-05	0.000244	CcSEcCtD
Clomipramine—Dermatitis—Prednisone—multiple sclerosis	5.51e-05	0.000244	CcSEcCtD
Clomipramine—Headache—Prednisone—multiple sclerosis	5.48e-05	0.000243	CcSEcCtD
Clomipramine—Hypersensitivity—Methotrexate—multiple sclerosis	5.39e-05	0.000238	CcSEcCtD
Clomipramine—Asthenia—Methotrexate—multiple sclerosis	5.25e-05	0.000232	CcSEcCtD
Clomipramine—Nausea—Prednisone—multiple sclerosis	5.2e-05	0.00023	CcSEcCtD
Clomipramine—Pruritus—Methotrexate—multiple sclerosis	5.17e-05	0.000229	CcSEcCtD
Clomipramine—Diarrhoea—Methotrexate—multiple sclerosis	5e-05	0.000221	CcSEcCtD
Clomipramine—Dizziness—Methotrexate—multiple sclerosis	4.84e-05	0.000214	CcSEcCtD
Clomipramine—Vomiting—Methotrexate—multiple sclerosis	4.65e-05	0.000206	CcSEcCtD
Clomipramine—Rash—Methotrexate—multiple sclerosis	4.61e-05	0.000204	CcSEcCtD
Clomipramine—Dermatitis—Methotrexate—multiple sclerosis	4.61e-05	0.000204	CcSEcCtD
Clomipramine—Headache—Methotrexate—multiple sclerosis	4.58e-05	0.000203	CcSEcCtD
Clomipramine—Diazepam—ALB—multiple sclerosis	4.52e-05	0.0611	CrCbGaD
Clomipramine—Nausea—Methotrexate—multiple sclerosis	4.34e-05	0.000192	CcSEcCtD
Clomipramine—Chlorpromazine—ALB—multiple sclerosis	4.19e-05	0.0568	CrCbGaD
Clomipramine—Amitriptyline—ALB—multiple sclerosis	4.15e-05	0.0561	CrCbGaD
Clomipramine—HTR2C—GPCR downstream signaling—CCR5—multiple sclerosis	1.86e-05	0.000294	CbGpPWpGaD
Clomipramine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.83e-05	0.00029	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—IL2RA—multiple sclerosis	1.83e-05	0.000289	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—SPP1—multiple sclerosis	1.81e-05	0.000287	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—IL2RA—multiple sclerosis	1.81e-05	0.000285	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	1.81e-05	0.000285	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	1.81e-05	0.000285	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—POMC—multiple sclerosis	1.8e-05	0.000284	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—CCL5—multiple sclerosis	1.79e-05	0.000283	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—POMC—multiple sclerosis	1.79e-05	0.000283	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CNR1—multiple sclerosis	1.77e-05	0.00028	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.77e-05	0.000279	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—CCR5—multiple sclerosis	1.77e-05	0.000279	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.76e-05	0.000278	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—CCL2—multiple sclerosis	1.75e-05	0.000277	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CXCL10—multiple sclerosis	1.75e-05	0.000276	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IL2RA—multiple sclerosis	1.74e-05	0.000275	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—IL2—multiple sclerosis	1.73e-05	0.000273	CbGpPWpGaD
Clomipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	1.72e-05	0.000272	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—CXCL10—multiple sclerosis	1.72e-05	0.000272	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—RRM1—multiple sclerosis	1.72e-05	0.000271	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CCL3—multiple sclerosis	1.71e-05	0.00027	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—CCR5—multiple sclerosis	1.69e-05	0.000267	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—IL2RA—multiple sclerosis	1.66e-05	0.000263	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—ALB—multiple sclerosis	1.66e-05	0.000261	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.65e-05	0.000261	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PTGER4—multiple sclerosis	1.65e-05	0.00026	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—POMC—multiple sclerosis	1.64e-05	0.000258	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—CCL5—multiple sclerosis	1.63e-05	0.000257	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—CCL5—multiple sclerosis	1.63e-05	0.000257	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—PGR—multiple sclerosis	1.62e-05	0.000256	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.62e-05	0.000255	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—CCR5—multiple sclerosis	1.61e-05	0.000255	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—APOE—multiple sclerosis	1.61e-05	0.000254	CbGpPWpGaD
Clomipramine—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	1.6e-05	0.000253	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—CCL2—multiple sclerosis	1.6e-05	0.000253	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CXCL10—multiple sclerosis	1.59e-05	0.000252	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—TYK2—multiple sclerosis	1.59e-05	0.000251	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—IL2RA—multiple sclerosis	1.59e-05	0.000251	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CXCR3—multiple sclerosis	1.59e-05	0.000251	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.58e-05	0.00025	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.58e-05	0.000249	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CD28—multiple sclerosis	1.58e-05	0.000249	CbGpPWpGaD
Clomipramine—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	1.57e-05	0.000248	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.55e-05	0.000244	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CCR2—multiple sclerosis	1.55e-05	0.000244	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CD86—multiple sclerosis	1.53e-05	0.000241	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.52e-05	0.00024	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CCL5—multiple sclerosis	1.5e-05	0.000237	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CCL3—multiple sclerosis	1.49e-05	0.000235	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—CCL5—multiple sclerosis	1.48e-05	0.000234	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.47e-05	0.000233	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—CCR5—multiple sclerosis	1.47e-05	0.000232	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—CCR5—multiple sclerosis	1.47e-05	0.000231	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—IL2—multiple sclerosis	1.46e-05	0.00023	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—TYK2—multiple sclerosis	1.45e-05	0.000229	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—POMC—multiple sclerosis	1.45e-05	0.000229	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—CD80—multiple sclerosis	1.45e-05	0.000229	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—IL2RA—multiple sclerosis	1.45e-05	0.000229	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—IL2RA—multiple sclerosis	1.44e-05	0.000228	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PTGER4—multiple sclerosis	1.43e-05	0.000226	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CNR1—multiple sclerosis	1.43e-05	0.000225	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—BCHE—multiple sclerosis	1.42e-05	0.000225	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—PGR—multiple sclerosis	1.41e-05	0.000222	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.39e-05	0.00022	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.39e-05	0.00022	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CD86—multiple sclerosis	1.39e-05	0.00022	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—SPP1—multiple sclerosis	1.39e-05	0.00022	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CXCR3—multiple sclerosis	1.38e-05	0.000218	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—POMC—multiple sclerosis	1.38e-05	0.000218	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CCL5—multiple sclerosis	1.37e-05	0.000217	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.37e-05	0.000216	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CD28—multiple sclerosis	1.37e-05	0.000216	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.36e-05	0.000215	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CCR5—multiple sclerosis	1.35e-05	0.000214	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CCL3—multiple sclerosis	1.35e-05	0.000213	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—CCL2—multiple sclerosis	1.35e-05	0.000213	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CCR2—multiple sclerosis	1.34e-05	0.000212	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—IL2—multiple sclerosis	1.34e-05	0.000212	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IL2RA—multiple sclerosis	1.33e-05	0.000211	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—CCR5—multiple sclerosis	1.33e-05	0.000211	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—IL2—multiple sclerosis	1.33e-05	0.00021	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—IL2—multiple sclerosis	1.32e-05	0.000209	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—MAPK1—multiple sclerosis	1.32e-05	0.000209	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—POMC—multiple sclerosis	1.32e-05	0.000208	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—IL2RA—multiple sclerosis	1.31e-05	0.000208	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.3e-05	0.000206	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PTGER4—multiple sclerosis	1.3e-05	0.000205	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—CCL2—multiple sclerosis	1.29e-05	0.000204	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CXCL10—multiple sclerosis	1.29e-05	0.000203	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—PGR—multiple sclerosis	1.28e-05	0.000202	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.28e-05	0.000201	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—SPP1—multiple sclerosis	1.27e-05	0.000201	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—POMC—multiple sclerosis	1.26e-05	0.000199	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CXCR3—multiple sclerosis	1.26e-05	0.000198	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CD28—multiple sclerosis	1.25e-05	0.000197	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CNR1—multiple sclerosis	1.24e-05	0.000196	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CCR5—multiple sclerosis	1.24e-05	0.000195	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—APOE—multiple sclerosis	1.23e-05	0.000195	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TYK2—multiple sclerosis	1.23e-05	0.000194	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CCR2—multiple sclerosis	1.22e-05	0.000193	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IL2RA—multiple sclerosis	1.22e-05	0.000192	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—IL2—multiple sclerosis	1.21e-05	0.000191	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—TYK2—multiple sclerosis	1.17e-05	0.000185	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.17e-05	0.000185	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—POMC—multiple sclerosis	1.15e-05	0.000181	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—POMC—multiple sclerosis	1.15e-05	0.000181	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CNR1—multiple sclerosis	1.13e-05	0.000178	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—APOE—multiple sclerosis	1.12e-05	0.000178	CbGpPWpGaD
Clomipramine—ALB—Metabolism—BCHE—multiple sclerosis	1.12e-05	0.000178	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CD86—multiple sclerosis	1.12e-05	0.000178	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—CCL2—multiple sclerosis	1.12e-05	0.000177	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CXCL10—multiple sclerosis	1.12e-05	0.000176	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CD80—multiple sclerosis	1.11e-05	0.000176	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CCL5—multiple sclerosis	1.11e-05	0.000175	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—IL2—multiple sclerosis	1.07e-05	0.00017	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.07e-05	0.000169	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.06e-05	0.000168	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—IL2—multiple sclerosis	1.06e-05	0.000167	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—POMC—multiple sclerosis	1.06e-05	0.000167	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.06e-05	0.000167	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—TGFB1—multiple sclerosis	1.05e-05	0.000165	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—POMC—multiple sclerosis	1.04e-05	0.000165	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CCL2—multiple sclerosis	1.04e-05	0.000164	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—MAPK1—multiple sclerosis	1.03e-05	0.000162	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—SPP1—multiple sclerosis	1.03e-05	0.000162	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IL2—multiple sclerosis	1.02e-05	0.000161	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—CCL2—multiple sclerosis	1.02e-05	0.000161	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—TYK2—multiple sclerosis	1.02e-05	0.000161	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CD80—multiple sclerosis	1.02e-05	0.000161	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CXCL10—multiple sclerosis	1.02e-05	0.00016	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—IL6—multiple sclerosis	1.02e-05	0.00016	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—MAPK1—multiple sclerosis	1.01e-05	0.00016	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.01e-05	0.000159	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CCR5—multiple sclerosis	9.97e-06	0.000157	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.91e-06	0.000157	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—BCHE—multiple sclerosis	9.85e-06	0.000156	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IL2RA—multiple sclerosis	9.83e-06	0.000155	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CD86—multiple sclerosis	9.76e-06	0.000154	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—IL2—multiple sclerosis	9.75e-06	0.000154	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—POMC—multiple sclerosis	9.66e-06	0.000153	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—MMP9—multiple sclerosis	9.65e-06	0.000152	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CCL5—multiple sclerosis	9.61e-06	0.000152	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CCL2—multiple sclerosis	9.45e-06	0.000149	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TYK2—multiple sclerosis	9.4e-06	0.000148	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—IL2—multiple sclerosis	9.33e-06	0.000147	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—BCHE—multiple sclerosis	9.28e-06	0.000147	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—TYK2—multiple sclerosis	9.26e-06	0.000146	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—MAPK1—multiple sclerosis	9.25e-06	0.000146	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.13e-06	0.000144	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—APOE—multiple sclerosis	9.07e-06	0.000143	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—SPP1—multiple sclerosis	8.9e-06	0.000141	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CD86—multiple sclerosis	8.88e-06	0.00014	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CCL5—multiple sclerosis	8.74e-06	0.000138	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CCR5—multiple sclerosis	8.66e-06	0.000137	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—STAT3—multiple sclerosis	8.58e-06	0.000136	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TYK2—multiple sclerosis	8.58e-06	0.000136	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—APOE—multiple sclerosis	8.57e-06	0.000135	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IL2RA—multiple sclerosis	8.53e-06	0.000135	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—IL2—multiple sclerosis	8.49e-06	0.000134	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—IL2—multiple sclerosis	8.47e-06	0.000134	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.32e-06	0.000131	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—TGFB1—multiple sclerosis	8.27e-06	0.000131	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CD80—multiple sclerosis	8.2e-06	0.00013	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—MAPK1—multiple sclerosis	8.11e-06	0.000128	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—SPP1—multiple sclerosis	8.1e-06	0.000128	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—MYC—multiple sclerosis	7.98e-06	0.000126	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TGFB1—multiple sclerosis	7.96e-06	0.000126	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—APOE—multiple sclerosis	7.88e-06	0.000124	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CCR5—multiple sclerosis	7.88e-06	0.000124	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—BCHE—multiple sclerosis	7.87e-06	0.000124	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IL2—multiple sclerosis	7.82e-06	0.000124	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—MAPK1—multiple sclerosis	7.8e-06	0.000123	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—POMC—multiple sclerosis	7.79e-06	0.000123	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—IL6—multiple sclerosis	7.78e-06	0.000123	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL2RA—multiple sclerosis	7.76e-06	0.000123	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—IL2—multiple sclerosis	7.71e-06	0.000122	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CCL2—multiple sclerosis	7.63e-06	0.00012	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—MAPK1—multiple sclerosis	7.46e-06	0.000118	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MMP9—multiple sclerosis	7.4e-06	0.000117	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—POMC—multiple sclerosis	7.36e-06	0.000116	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—APOE—multiple sclerosis	7.17e-06	0.000113	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IL2—multiple sclerosis	7.14e-06	0.000113	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CD80—multiple sclerosis	7.12e-06	0.000112	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—IL6—multiple sclerosis	7.11e-06	0.000112	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TYK2—multiple sclerosis	6.92e-06	0.000109	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—POMC—multiple sclerosis	6.77e-06	0.000107	CbGpPWpGaD
Clomipramine—ALB—Metabolism—APOE—multiple sclerosis	6.76e-06	0.000107	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MMP9—multiple sclerosis	6.76e-06	0.000107	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—ALB—multiple sclerosis	6.71e-06	0.000106	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CCL2—multiple sclerosis	6.62e-06	0.000105	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—STAT3—multiple sclerosis	6.58e-06	0.000104	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CD80—multiple sclerosis	6.48e-06	0.000102	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—MAPK1—multiple sclerosis	6.48e-06	0.000102	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—POMC—multiple sclerosis	6.16e-06	9.72e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MYC—multiple sclerosis	6.12e-06	9.66e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TGFB1—multiple sclerosis	6.1e-06	9.64e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—APOE—multiple sclerosis	6.07e-06	9.59e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—BCHE—multiple sclerosis	6.07e-06	9.58e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CCL2—multiple sclerosis	6.02e-06	9.51e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TYK2—multiple sclerosis	6.01e-06	9.49e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—STAT3—multiple sclerosis	6.01e-06	9.49e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IL6—multiple sclerosis	6e-06	9.47e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MAPK1—multiple sclerosis	5.98e-06	9.45e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—APOE—multiple sclerosis	5.93e-06	9.36e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—MAPK1—multiple sclerosis	5.89e-06	9.31e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—POMC—multiple sclerosis	5.81e-06	9.18e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IL2—multiple sclerosis	5.76e-06	9.1e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—IL6—multiple sclerosis	5.73e-06	9.05e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—APOE—multiple sclerosis	5.59e-06	8.82e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MYC—multiple sclerosis	5.58e-06	8.82e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TGFB1—multiple sclerosis	5.57e-06	8.8e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TYK2—multiple sclerosis	5.47e-06	8.64e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MAPK1—multiple sclerosis	5.46e-06	8.63e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MMP9—multiple sclerosis	5.45e-06	8.61e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—POMC—multiple sclerosis	5.22e-06	8.24e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—POMC—multiple sclerosis	5.09e-06	8.04e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IL2—multiple sclerosis	5e-06	7.9e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—IL6—multiple sclerosis	4.98e-06	7.86e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—STAT3—multiple sclerosis	4.85e-06	7.66e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—POMC—multiple sclerosis	4.8e-06	7.58e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ALB—multiple sclerosis	4.76e-06	7.51e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MMP9—multiple sclerosis	4.74e-06	7.48e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—APOE—multiple sclerosis	4.73e-06	7.47e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—ALB—multiple sclerosis	4.64e-06	7.33e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IL6—multiple sclerosis	4.6e-06	7.26e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL2—multiple sclerosis	4.55e-06	7.19e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—IL6—multiple sclerosis	4.53e-06	7.15e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MYC—multiple sclerosis	4.51e-06	7.11e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TGFB1—multiple sclerosis	4.49e-06	7.1e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MAPK1—multiple sclerosis	4.41e-06	6.96e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ALB—multiple sclerosis	4.37e-06	6.91e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MMP9—multiple sclerosis	4.31e-06	6.8e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—STAT3—multiple sclerosis	4.21e-06	6.65e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IL6—multiple sclerosis	4.2e-06	6.63e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—POMC—multiple sclerosis	4.06e-06	6.42e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MYC—multiple sclerosis	3.91e-06	6.18e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TGFB1—multiple sclerosis	3.9e-06	6.16e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—STAT3—multiple sclerosis	3.83e-06	6.05e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MAPK1—multiple sclerosis	3.83e-06	6.04e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ALB—multiple sclerosis	3.71e-06	5.85e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—APOE—multiple sclerosis	3.65e-06	5.77e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MYC—multiple sclerosis	3.56e-06	5.62e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TGFB1—multiple sclerosis	3.55e-06	5.61e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MAPK1—multiple sclerosis	3.48e-06	5.5e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IL6—multiple sclerosis	3.39e-06	5.35e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—POMC—multiple sclerosis	3.14e-06	4.95e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IL6—multiple sclerosis	2.94e-06	4.64e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ALB—multiple sclerosis	2.86e-06	4.52e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL6—multiple sclerosis	2.68e-06	4.22e-05	CbGpPWpGaD
